- $111.81m
- $91.61m
- $228.53m
- 99
- 79
- 21
- 75
Annual balance sheet for Lifevantage, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 23.2 | 20.2 | 21.6 | 16.9 | 20.2 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 3.96 | 5.09 | 1.85 | 3.26 | 3.93 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 48.1 | 47 | 44.3 | 37.6 | 50.9 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 24.8 | 20.5 | 17.8 | 17.4 | 14.2 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 78.7 | 70.7 | 66.1 | 60.3 | 72 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 25.2 | 25.7 | 19.6 | 22.3 | 27.2 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 41.9 | 39.2 | 31.5 | 34.3 | 37.3 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 36.8 | 31.5 | 34.6 | 26 | 34.6 |
| Total Liabilities & Shareholders' Equity | 78.7 | 70.7 | 66.1 | 60.3 | 72 |
| Total Common Shares Outstanding |